Indications and uses
to soothe: • itching • flea bites • dermatitis • skin irritations • eczema
to soothe: • itching • flea bites • dermatitis • skin irritations • eczema
• shake well before use • holds sprayer 4-6 inches away and spray directly on affected area • apply 2-3 times until relief is achieved • for best results, cleanse affected area prior to using this product • avoid contact with the eyes • individual results may vary
Hydrocortisone Acetate 0.50%
Anti-itch
to soothe: • itching • flea bites • dermatitis • skin irritations • eczema
For external use only. Use for all adult dogs.
and animals to avoid unintended consumption. Do not use if product appears to be tampered with.
• in eyes or nose • where infection (pus) is present, since the drug may allow infection to be spread • on pregnant animals.
Not for prolonged use. Do not apply to large areas areas of the body.
if redness, irritation, or swelling persists or increases.
• shake well before use
• holds sprayer 4-6 inches away and spray directly on affected area
• apply 2-3 times until relief is achieved
• for best results, cleanse affected area prior to using this product
• avoid contact with the eyes
• individual results may vary
Store product in cool. dry place. Avoid temperatures above 86F.
Deionized Water, Propylene Glycol USP, Dimethyl Sulfoxide.
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| HYDROCORTISONE ACETATE | ACTIVE INGREDIENT | 3X7931PO74 | 4 | |
| HYDROCORTISONE | ACTIVE MOIETY | WI4X0X7BPJ | 4 | |
| DIMETHYL SULFOXIDE | INACTIVE INGREDIENT | YOW8V9698H | 4 | |
| PROPYLENE GLYCOL | INACTIVE INGREDIENT | 6DC9Q167V3 | 4 | |
| Water | INACTIVE INGREDIENT | 059QF0KO0R | 4 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 60754-923 | 60754-923-04 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| HYDROCORTISONE ACETATE | 3X7931PO74 | ACTIB |
| Water | 059QF0KO0R | IACT |
| PROPYLENE GLYCOL | 6DC9Q167V3 | IACT |
| DIMETHYL SULFOXIDE | YOW8V9698H | IACT |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | TABLET, DELAYED RELEASE / ORAL | 36 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | CAPSULE, DELAYED RELEASE / ORAL | 1.7 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | OINTMENT, AUGMENTED / TOPICAL | 714 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | CAPSULE, EXTENDED RELEASE / ORAL | 8 mg | ||
| DIMETHYL SULFOXIDE | DIMETHYL SULFOXIDE | YOW8V9698H | SOLUTION / TOPICAL | 8008 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | SUSPENSION / RECTAL | 90400 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | JELLY / TOPICAL | 20 %w/w | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | SOLUTION/ DROPS / OPHTHALMIC | 0.75 %w/v | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | SPRAY / SUBLINGUAL | 36 mg | ||
| DIMETHYL SULFOXIDE | DIMETHYL SULFOXIDE | YOW8V9698H | INJECTION, POWDER, FOR SUSPENSION / INTRAVENOUS | NA | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | GEL / TOPICAL | 4522 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | TABLET / ORAL | 64 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | SOLUTION, CONCENTRATE / ORAL | 2590 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | TABLET, FILM COATED / ORAL | 96 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | INJECTION / INTRAVENOUS | 16624 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | ELIXIR / ORAL | 9306 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | SUSPENSION / AURICULAR (OTIC) | 10 %w/v | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 19 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | SOLUTION, CONCENTRATE / INTRAVENOUS | 50.33 %w/v | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | EMULSION / TOPICAL | 8 %w/w | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | INJECTION, SOLUTION / SUBCUTANEOUS | 1.4 %w/v | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | GEL / OPHTHALMIC | 0.44 %w/w | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | EMULSION / OPHTHALMIC | 1.5 %w/v | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | SUSPENSION/ DROPS / OPHTHALMIC | 0.75 %w/v | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | INJECTION / SUBCUTANEOUS | 1.4 %w/v | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | SOLUTION/ DROPS / AURICULAR (OTIC) | ADJ PH | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | SUSPENSION/ DROPS / TOPICAL | 0.75 %w/v | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | SPRAY / NASAL | 5 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | SWAB / TOPICAL | 34.6 %w/w | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | AEROSOL / TOPICAL | 19.2 %w/w | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | GEL / VAGINAL | 750 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | SHAMPOO / TOPICAL | 8 %w/w | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | SPRAY, METERED / NASAL | 240 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | AEROSOL, FOAM / TOPICAL | 1800 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | TABLET, EXTENDED RELEASE / ORAL | 9 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | PASTE / DENTAL | 0.5 %w/w | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | SOLUTION / ORAL | 22602 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | DROPS / ORAL | 200 mg/1ml | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS | 63.4 %w/v | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | INJECTION, SOLUTION / INTRAVENOUS | 4000 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | AEROSOL, FOAM / VAGINAL | 6.4 %w/w | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | LIQUID / ORAL | 29008 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | SUPPOSITORY / VAGINAL | 252 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | CLOTH / TOPICAL | 0.03 mg/mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | CAPSULE / ORAL | 1072 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | SHAMPOO, SUSPENSION / TOPICAL | 2 %w/w | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | GEL, METERED / TOPICAL | 1225 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | SYRUP / ORAL | 5700 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | LOTION, AUGMENTED / TOPICAL | 2070 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | SOLUTION / INTRAVENOUS | 5 %w/v | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | CREAM / TOPICAL | 76000 mg | ||
| DIMETHYL SULFOXIDE | DIMETHYL SULFOXIDE | YOW8V9698H | LOTION / TOPICAL | 45.5 %w/w | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | FILM, EXTENDED RELEASE / TRANSDERMAL | 58.13 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | OINTMENT / DENTAL | NA | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | SUSPENSION / ORAL | 27120 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | SUSPENSION / TOPICAL | 5.28 %w/v | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | CREAM, AUGMENTED / TOPICAL | 8 %w/w | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | GEL / RECTAL | 3315 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | FILM / BUCCAL | 1.48 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | AEROSOL, FOAM / RECTAL | 1214 mg |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Hydrocortisone | HYDROCORTISONE | American Health Packaging | 506aab0d-9308-4d60-90b3-7d64952fff36 | 2026-08-31 | Warnings, Adverse reactions | Hydrocortisone |
| Hydrocortisone Acetate | HYDROCORTISONE ACETATE | Preferred Pharmaceuticals, Inc. | 247bb729-f0b6-4325-a9f8-4b46d5cda300 | 2026-08-28 | Adverse reactions | HYDROCORTISONE ACETATE |
| Hydrocortisone | HYDROCORTISONE | Amazon.com Services LLC | 5f87d7fb-f258-48b0-8b60-1055e22ebd71 | 2026-08-25 | Warnings | Hydrocortisone |
| Claravie | HYDROCORTISONE ACETATE | Gentell LLC | 598d224b-d12e-89bf-e063-6394a90a84dc | 2026-08-21 | Warnings | HYDROCORTISONE ACETATE |
| Hydrocortisone | HYDROCORTISONE | Safetec of America, Inc. | da2b3b2c-11e0-401b-bbd2-d019271d1b3d | 2026-08-13 | Warnings | Hydrocortisone |
| HYDROCORTISONE | HYDROCORTISONE | Amazon.com Services LLC | f40b4223-e81f-4cd0-bc9b-d3d33ce8cce5 | 2026-08-12 | Warnings | HYDROCORTISONE |
| Hydrocortisone | HYDROCORTISONE | Solco Healthcare LLC | 04f112e5-ec88-46c8-b675-8b4e38a86ab4 | 2026-08-11 | Warnings, Adverse reactions | Hydrocortisone |
| hydrocortisone | HYDROCORTISONE | Bryant Ranch Prepack | 484fe5e4-a058-49c0-a382-c8fc3e20c3b2 | 2026-08-04 | Warnings | hydrocortisone |
| procure | HYDROCORTISONE ACETATE | TWIN MED, LLC | 2670c9c4-66ad-40e8-a08a-582b160de39d | 2026-08-03 | Warnings | HYDROCORTISONE ACETATE |
| Hydrocortisone | HYDROCORTISONE | REMEDYREPACK INC. | f0e66726-946b-4f63-b457-2851dc69e6b4 | 2026-08-03 | Adverse reactions | Hydrocortisone |
| hydrocortisone | HYDROCORTISONE | Eywa Pharma Inc | b3f06d10-2f01-428c-88a4-505c61c87ce8 | 2026-07-25 | Warnings, Adverse reactions | hydrocortisone |
| Hydrocortisone | HYDROCORTISONE | AKRON PHARMA INC | daad9a1e-98d2-4ce7-9d97-ac5d81905abb | 2026-07-22 | Warnings | Hydrocortisone |
| Hydrocortisone | HYDROCORTISONE LOTION | Allegis Holdings LLC | 1a27d8fa-4025-ed68-e063-6394a90a4f37 | 2026-07-08 | Warnings, Adverse reactions | Hydrocortisone |
| Hydrocortisone | HYDROCORTISONE | Encube Ethicals, Inc. | 11e120e2-a1ca-477c-b474-bcbb72656705 | 2026-06-26 | Adverse reactions | Hydrocortisone |
| Hydrocortisone | HYDROCORTISONE | Mylan Pharmaceuticals Inc. | bc751403-94f2-4f9d-b533-cf6186a40ceb | 2026-05-25 | Warnings, Adverse reactions | Hydrocortisone |
| Hydrocortisone | HYDROCORTISONE | Bryant Ranch Prepack | 04758c46-0ca4-4852-acdc-1f8553ce2e6e | 2026-05-21 | Adverse reactions | Hydrocortisone |
| Hydrocortisone | HYDROCORTISONE | Preferred Pharmaceuticals Inc. | 02ab1006-c7c8-42c9-bda8-62c9d7142521 | 2026-05-11 | Adverse reactions | Hydrocortisone |
| Hydrocortisone | HYDROCORTISONE | Preferred Pharmaceuticals, Inc. | 058bb2ff-ff51-4a3b-ba47-cb02272d0631 | 2026-05-11 | Adverse reactions | Hydrocortisone |
| hydrocortisone | HYDROCORTISONE | Preferred Pharmaceuticals Inc. | 12cd35e3-e707-4551-b778-bf615c1a8d32 | 2026-05-11 | Warnings | hydrocortisone |
| HYDROCORTISONE | HYDROCORTISONE | Preferred Pharmaceuticals Inc. | 0bbb8a63-ae1d-41d7-b201-d1b171b31f46 | 2026-05-11 | Warnings, Adverse reactions | HYDROCORTISONE |
Adverse event summaries are temporarily unavailable. Other product information remains available.